Senegal’s locally manufactured DREPAF, a generic hydroxyurea treatment for sickle cell disease, is reducing medicine costs and addressing supply challenges while raising hopes for improved access across Africa.
Tag: African Healthcare
Experts Urge Africa to Unlock Domestic Capital as Health Funding Declines!
African experts are urging governments to unlock domestic capital, pension funds and other financing mechanisms as declining donor support puts pressure on healthcare systems.